Encompass Health Corp 8-K

What Happened
Encompass Health Corporation announced on May 14, 2026 (filed 8-K May 15, 2026) that it entered into a purchase agreement with Wells Fargo Securities, LLC, as representative of the initial purchasers, for a private offering of $500,000,000 aggregate principal amount of 5.875% senior notes due 2034, with certain subsidiaries serving as guarantors. The offering is expected to close on or about May 29, 2026. The notes are being offered in a transaction exempt from registration under the Securities Act and will be resold to qualified institutional buyers (Rule 144A) and non‑U.S. persons (Regulation S).

Key Details

• Offering size and terms: $500,000,000 aggregate principal of 5.875% senior notes due 2034.
• Use of proceeds: Company intends to redeem $400M of its 4.500% senior notes due 2028 at par, repay $100M of its revolving credit facility, and pay related fees and expenses.
• Counterparties and timing: Purchase Agreement dated May 14, 2026, with Wells Fargo Securities, LLC as representative; expected closing on or about May 29, 2026.
• Distribution and registration: Notes and guarantees will not be registered under the Securities Act; resales to QIBs under Rule 144A and to non‑U.S. persons under Regulation S.

Why It Matters
This transaction affects Encompass Health’s debt profile and near‑term capital structure: the company plans to use proceeds to retire a portion of higher‑priority 2028 debt and reduce amounts drawn on its revolver, which can lower near‑term interest obligations and refinance risk. Investors should note the new long‑dated 2034 debt carries a 5.875% coupon and is being placed privately with institutional investors, which may influence the company’s interest expenses and credit metrics going forward. The 8-K also references a press release announcing the pricing and includes customary representations and indemnities in the purchase agreement.